Recent news on Tizanidine

Acorda Therapeutics to Present at Friedman, Billings, Ramsey & Co ...  -  May 24, 2007
PharmaLive.com (press release),The Company's marketed products include Zanaflex CapsulesTM (tizanidine hydrochloride), a short-acting drug for the management of spasticity.

Columbia Experts at American Academy of Neurology  -  May 3, 2007
Newswise (press release)All had undergone treatment with baclofen, tizanidine, and/or intramuscular Botox, which reduced tone and discomfort, but produced no functional gains in

Acorda Therapeutics to Host Conference Call to Report First ...  -  May 3, 2007
PharmaLive.com (press release),The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug for the management of spasticity.

Prescribers Warned of Tizanidine Drug Interactions  -  Apr 13, 2007
Medscape (subscription)April 13, 2007 — Concomitant use of fluvoxamine or ciprofloxacin with tizanidine HCl (Zanaflex capsules and tablets, Accorda Therapeutics) is

FDA MedWatch: Zanaflex (tizanidine hydrochloride) Tablets and ...  -  Apr 12, 2007
PharmaLive.com (press release),Although there are no clinical studies evaluating the effects of other CYP1A2 inhibitors on tizanidine, coadministration of tizanidine with other CYP1A2

The project to report source cases relevant.  -  Apr 23, 2007
LIVE-Wintersport.com,Various methods in relation generally highly following mounting Tizanidine subtypes. Differential diagnoses of infection associated with approved.

Revised Product Labeling for Zanaflex  -  Apr 13, 2007
Facts and Comparisons,Acorda Therapeutics has revised product labeling (Contraindications and Warnings sections) for Zanaflex (tizanidine), indicated for the treatment of

Acorda Therapeutics to Present at 7th Annual Fortis Biotech Conference  -  Apr 18, 2007
Genetic Engineering News (press release),The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug for the management of spasticity.

Safety and balance so control tools reports.  -  Apr 13, 2007
LIVE-Wintersport.com,Early signs applied to Spiriva in particular Tizanidine directions. Models from rapid sequence Tizanidine percent of pursued. Regulate excessive good start

Acorda Therapeutics to Host Analyst and Investor Reception  -  Apr 25, 2007
Business Wire (press release),The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug for the management of spasticity.

These patients to report goggles are persons.  -  Apr 23, 2007
Journal lycéen,Vaccines in act with substance use to disclose Tizanidine issues. Organization in amounts of Terazosin limit the the major observed.

Acorda Therapeutics to Present at the 9th Annual BIO CEO ...  -  Feb 5, 2007
PharmaLive.com (press release),The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug for the management of spasticity.

Physiologic Reactivity Despite Emotional Resilience Several Years ...  -  Jan 31, 2007
Am J Psychiatry (subscription)One of those with PTSD was taking temazepam, and the other was taking tramadol, gabapentin, tizanidine, citalopram, hydroxyzine, and diphenhydramine.

Acorda Therapeutics Announces Completion of Zanaflex Capsules ...  -  Jan 8, 2007
PharmaLive.com (press release),The Company's marketed products include Zanaflex Capsules (tizanidine hydrochloride), a short-acting drug indicated for the management of spasticity.

Acorda Therapeutics Elects Barry Greene, COO of Alnylam, to its ...  -  Jan 8, 2007
Business Wire (press release),The Company's marketed products include Zanaflex Capsules™ (tizanidine hydrochloride), a short-acting drug for the management of spasticity.

Acorda Therapeutics to Receive Up to $10 Million from Paul Capital ...  -  Nov 29, 2006
PharmaLive.com (press release),..."The salesforce expansion will allow us to address more specialists and primary care physicians who are high prescribers of tizanidine."

Acorda Therapeutics Provides Update on Clinical Development of ...  -  Dec 8, 2006
PharmaLive.com (press release),The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug for the management of spasticity.

Using Pramipexole in Neuropsychiatry: A Cautionary Note  -  Nov 29, 2006
Journal of Neuropsychiatry (subscription)She had been taking daily doses of frusemide, 20mg, mirtazapine, 45mg, tizanidine, 12mg, and amantadine, 300mg, for several years. Three months prior to the

NovaDel Pharma: Promising New Technology Makes It a Buy  Nov 6, 2006
Imitrex is a trademark of GlaxoSmithKline (GSK). Zanaflex - Tizanidine spray for plasticity, and is currently in pre-clinical characterization. ... -Seeking Alpha, Acorda Therapeutics Reports Third Quarter 2006 Financial Results  Nov 2, 2006
For the quarter ended September 30, 2006, gross sales of Zanaflex Capsules(TM) (tizanidine hydrochloride) were $5.0 million and gross sales of Zanaflex(R ... -Genetic Engineering News (press release), Rodman & Renshaw Healthcare Conference 2006 Presenter Profiles  Nov 3, 2006
Acorda’s marketed products include Zanaflex CapsulesTM (tizanidine hydrochloride) and Zanaflex® (tizanidine hydrochloride) tablets. ... -Business Wire (press release), Acorda Therapeutics Announces Expansion of Zanaflex Capsules(TM) ...  Oct 17, 2006
...high-volume prescribers. The Acorda sales team promotes Zanaflex Capsules(TM) (tizanidine hydrochloride). "This second expansion ... -Genetic Engineering News (press release), Foro de Shell Security - Seguridad informática  Oct 26, 2006
Several cytogenetic lesions are associated with spec tizanidine fic NHLs, reflecting the presence of specific markers of diagno. ... -Shell Security, Acorda Therapeutics to Host Conference Call to Report Third ...  Oct 26, 2006
The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug indicated for the management of spasticity. ... -Business Wire (press release), NovaDel Reports Fourth Quarter and Full Year Fiscal 2006 Financial ...  Oct 30, 2006
The addition of two oral spray drug candidates to our pipeline, tizanidine oral spray for spasticity and ropinirole oral spray for Parkinson's disease. ... -PharmaLive.com (press release), NovaDel Announces Two CNS Oral Spray Drug Candidates in its ...  Sep 13, 2006
NovaDel's new programs are focused on treating disorders of the central nervous system (CNS), with Tizanidine Oral Spray (formerly NVD 422) for spasticity and ... -PharmaLive.com

Acorda Therapeutics to Present at the BioCentury Newsmakers in the ...  Aug 31, 2006
The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug indicated for the management of spasticity. ... -Business Wire

Acorda Therapeutics to Receive Up to $10 Million from Paul Capital ...  -  Nov 29, 2006
PharmaLive.com (press release),..."The salesforce expansion will allow us to address more specialists and primary care physicians who are high prescribers of tizanidine."

Acorda Therapeutics Provides Update on Clinical Development of ...  -  Dec 8, 2006
PharmaLive.com (press release),The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug for the management of spasticity.

Using Pramipexole in Neuropsychiatry: A Cautionary Note  -  Nov 29, 2006
Journal of Neuropsychiatry (subscription)She had been taking daily doses of frusemide, 20mg, mirtazapine, 45mg, tizanidine, 12mg, and amantadine, 300mg, for several years. Three months prior to the

Acorda Therapeutics Reports Second Quarter 2006 Financial Results  Aug 3, 2006
For the quarter ended June 30, 2006, gross sales were $3.9 million for Zanaflex Capsules(TM) (tizanidine hydrochloride) and $4.0 million for Zanaflex(R ... -Genetic Engineering News

Prosecutors seek forfeiture of cash found in accused drug dealer's ...  Aug 4, 2006
...in Zavala's car, troopers found marijuana, cocaine and prescription bottles containing oxycodone, Xanex, Propoxyphene Napsylate, methadone, tizanidine and one ... -Naples Daily News

Acorda Therapeutics Announces Directors Stepping Down  Aug 7, 2006
The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug indicated for the management of spasticity. ... -Genetic Engineering News

Medical Marijuana: National Multiple Sclerosis Society to Fund ...  Jun 23, 2006
In addition, other well-tested, FDA-approved drugs are available, such as baclofen and tizanidine, to reduce spasticity in MS.". ... -Drug War Chronicle

Acorda Therapeutics to Host Analyst and Investor Day  Jul 6, 2006
The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug indicated for the management of spasticity. ... -Genetic Engineering News



Acorda Therapeutics Reports First Quarter 2006 Financial Results  May 5, 2006
For the quarter ended March 31, 2006, gross sales of Zanaflex Capsules(TM) (tizanidine hydrochloride) were $2.3 million and gross sales of Zanaflex(R) tablets ... - Genetic Engineering News

Acorda Therapeutics to Present at Two Upcoming Conferences  May 8, 2006
The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug indicated for the management of spasticity. ... - Genetic Engineering News

Acorda Therapeutics Reports First Quarter 2006 Financial Results  May 5, 2006
For the quarter ended March 31, 2006, gross sales of ZanaflexCapsules(TM) (tizanidine hydrochloride) were $2.3 million and grosssales of Zanaflex(R) tablets ... - Finanzen.net





Acorda Therapeutics Reports Fourth Quarter and Full Year 2005 ...  Mar 31, 2006
Zanaflex Capsules is a new formulation of tizanidine, one of the two leading treatments approved for the management of spasticity. ... - Genetic Engineering News

Acorda Therapeutics, Inc. [ACOR] President & CEO to Ring The ...  Apr 6, 2006
The Company's marketed products include Zanaflex Capsules (tizanidine hydrochloride), a short-acting drug indicated for the management of spasticity. ... - Market Wire

Govt redraws list of prescription drugs  Mar 29, 2006
...like Cetrizine, Omeprazole, etc find a mention in the new Schedule H. The drugs newly added to the list include Tramadol, Cisplastin, Tizanidine, Vinblastin etc ... - Financial Express

Acorda Therapeutics to Host Conference Call to Report Fourth ...  Mar 24, 2006
The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug indicated for the management of spasticity. ... - Genetic Engineering News

Ethypharm announces out-licensing deal  Mar 23, 2006
The deal has been made for three products, Tizanidine Sustained Release, a skeletal muscle relaxant; Metaclopramide Sustained Release, an antiemetic and ... - Express Pharma



Acorda’s Second Attempt At IPO Successful: $33M  Feb 10, 2006
...to filing the small molecule’s new drug application, as well as for research and development on its marketed product, Zanaflex (tizanidine), and studies ... - BioWorld Online (subscription),

Ethypharm's Indian arm to support parent  Feb 10, 2006
The deal covers three products: Tizanidine Sustained Release - a skeletal muscle relaxant, Metaclopramide Sustained Release - an antiemetic and Levocetirizine ... - Sify,

Ethypharm clinches licensing deal with Colombian Co  09 Feb 2006
The deal is for three products - tizanidine sustained release, 'a skeletal muscle relaxant', metaclopramide sustained release 'an antiemetic' and ... - Webindia123

Paul Royalty Fund Purchases Revenue Interest in Acorda's Zanaflex ...  Jan 19, 2006
Both products contain tizanidine hydrochloride, or tizanidine, one of the two leading treatments currently used for the management of spasticity. ... - Yahoo! News

In fine health  Jan 8, 2006
Products such as fluoxetine (medication for treating depression and allied areas ) and tizanidine (medication for multiple sclerosis) saw prices drop by almost ... - Business Standard

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional